Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021

SELL
$85.24 - $94.15 $7,160 - $7,908
-84 Closed
0 $0
Q4 2019

Feb 03, 2020

SELL
$84.35 - $95.37 $7,254 - $8,201
-86 Reduced 50.59%
84 $8,000
Q3 2019

Oct 23, 2019

SELL
$85.54 - $94.26 $78,183 - $86,153
-914 Reduced 84.32%
170 $15,000
Q2 2019

Jul 31, 2019

BUY
$75.4 - $92.8 $44,410 - $54,659
589 Added 118.99%
1,084 $99,000
Q3 2018

Oct 24, 2018

BUY
$66.94 - $77.43 $33,135 - $38,327
495 New
495 $43,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $226B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Capital Advisors, Ltd. LLC Portfolio

Follow Capital Advisors, Ltd. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.